Early Abnormal Nailfold Capillary Changes Are Predictive of Calcinosis Development in Juvenile Dermatomyositis.


Journal

The Journal of rheumatology
ISSN: 0315-162X
Titre abrégé: J Rheumatol
Pays: Canada
ID NLM: 7501984

Informations de publication

Date de publication:
11 2022
Historique:
accepted: 24 06 2022
pubmed: 2 8 2022
medline: 4 11 2022
entrez: 1 8 2022
Statut: ppublish

Résumé

The long-term outcomes of juvenile dermatomyositis (JDM) are more favorable in recent years. However, calcinosis is still among the complications that can cause serious functional impairment. Little is known about the pathogenesis and risk factors of calcinosis. The aim of this study is to determine risk factors for the development of calcinosis in JDM. This was a single-center, retrospective cohort study. All patients were diagnosed and followed at the multidisciplinary JDM clinic of The Hospital for Sick Children, from January 1, 1989, until May 31, 2018. To investigate predictors of incident calcinosis, Cox regression analysis was performed. A total of 172 patients met inclusion criteria, with a median age at diagnosis of 7.7 years (IQR 4.9-12.1), and a median follow-up of 8.5 years (IQR 3.4-12.6, range 0.1-28.3). The only risk factor significantly associated with the development of calcinosis in the univariate analysis was nailfold abnormality at baseline (hazard ratio [HR] 4.86, The presence of abnormal nailfold capillary changes at baseline is predictive for the development of calcinosis in children with idiopathic inflammatory myopathies.

Identifiants

pubmed: 35914785
pii: jrheum.220249
doi: 10.3899/jrheum.220249
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1250-1255

Informations de copyright

Copyright © 2022 by the Journal of Rheumatology.

Auteurs

Tomo Nozawa (T)

T. Nozawa, MD, Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada, and Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama City, Kanagawa, Japan; tnozawa@yokohama-cu.ac.jp.

Audrey Bell-Peter (A)

A. Bell-Peter, RN, MN, Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Jo-Anne Marcuz (JA)

J. Marcuz, MSc, PT, K. Whitney, MSc, PT, Division of Rheumatology, and Department of Rehabilitation, The Hospital for Sick Children, Toronto, Ontario, Canada.

Kristi Whitney (K)

J. Marcuz, MSc, PT, K. Whitney, MSc, PT, Division of Rheumatology, and Department of Rehabilitation, The Hospital for Sick Children, Toronto, Ontario, Canada.

Ophir Vinik (O)

O. Vinik, MD, R. Shupak, MD, Division of Rheumatology, Saint Michael's Hospital, Toronto, Ontario, Canada.

Rachel Shupak (R)

O. Vinik, MD, R. Shupak, MD, Division of Rheumatology, Saint Michael's Hospital, Toronto, Ontario, Canada.

Saunya Dover (S)

S. Dover, MSc, Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.

Brian M Feldman (BM)

B.M. Feldman, MD, Division of Rheumatology, The Hospital for Sick Children, Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, and Departments of Pediatrics and Institute of Health Policy Management & Evaluation, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH